Effectiveness and side effects of Syanapress (subcutaneous depot medroxyprogesterone) in females of reproductive age groups

Abstract

Background: Sayana Press® (injectable contraceptive) is associated with a high level of contraceptive efficacy. It is fascinating that the effectiveness of Sayana Press is sustained even if the time of injection is prolonged from the usual three to four months. Objective: To study the effectiveness and side effects of Sayana Press in females of reproductive age to change existing contraceptive practices. Methodology: This descriptive case series was done in a six-month duration (01-04-2023 to 30-09-2023) at the department of obstetrics and gynecology at Lady Aitchison Hospital, which enrolled 96 females after informed consent and followed up for the study duration. We obtained ethical approval and informed consent prior to conducting the study. We used SPSS-v26 for data analysis.

Results: We selected 96 females of reproductive age for this study. The mean age of the patients was 31.95±5.06 years. Among 96 patients, 22 (22.9%) were nulliparous, 35 (36.5%) were primiparous, and 39 (40.6%) were multiparous. According to the efficacy of Sayana Press, it was efficacious in 66 (68.7%) patients, and 30 (31.3%) had side effects. Conclusion: The findings of the study revealed that Sayana Press was deemed satisfactory by the women within our specific demographic. The information provided by this study is of importance as it provides significant perception to the government and serves as a pivotal milestone towards the potential implementation of Sayana Press.